According to NRx Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | -0.9703 | -70.94% |
2023-12-31 | -3.34 | -132.95% |
2022-12-31 | 10.1 | -25% |
2021-12-31 | 13.5 | |
2020-12-31 | N/A |